ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

ClinicalTrials.gov ID: NCT06897475

Public ClinicalTrials.gov record NCT06897475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel-Group Treatment, Phase 2, Double-Blind Study of Once-Weekly Subcutaneous LY3457263 Compared to Placebo in Participants With Type 2 Diabetes Mellitus on a Stable Dose of Semaglutide or Tirzepatide Who Failed to Achieve HbA1c Goal

Study identification

NCT ID
NCT06897475
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • LY3457263 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2025
Primary completion
Nov 30, 2026
Completion
Dec 31, 2026
Last update posted
Apr 16, 2026

2025 – 2027

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Helios Clinical Research - Phoenix Phoenix Arizona 85028 Recruiting
Wolverine Clinical Trials Santa Ana California 92706 Recruiting
Renstar Medical Research Ocala Florida 34471 Recruiting
Oviedo Medical Research Oviedo Florida 32765 Recruiting
Balanced Life Health Care Solutions/SKYCRNG Lawrenceville Georgia 30046 Recruiting
Physicians Research Associates Lawrenceville Georgia 30046 Not yet recruiting
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291 Recruiting
North Georgia Clinical Research Woodstock Georgia 30189 Not yet recruiting
Elite Clinical Trials Rexburg Idaho 83440 Recruiting
Investigators Research Group Brownsburg Indiana 46112 Recruiting
Clinical Research of Philadelphia Pennington New Jersey 08534 Not yet recruiting
NYC Research INC Long Island City New York 11106 Not yet recruiting
Richmond University Medical Center Staten Island New York 10310 Recruiting
Southgate Medical Group West Seneca New York 14224 Recruiting
Lucas Research, Inc. Morehead City North Carolina 28557 Recruiting
Shelby Clinical Research Shelby North Carolina 28150 Recruiting
Providence Health Partners-Center for Clinical Research Dayton Ohio 45439 Recruiting
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069 Recruiting
Frontier Clinical Research, LLC Scottdale Pennsylvania 15683 Not yet recruiting
Juno Research Houston Texas 77040 Recruiting
Southern Endocrinology Associates Mesquite Texas 75149 Recruiting
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 Recruiting
Consano Clinical Research, LLC Shavano Park Texas 78231 Recruiting
Texas Valley Clinical Research Weslaco Texas 78596 Recruiting
Eastside Research Associates Redmond Washington 98052 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06897475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06897475 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →